Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy
about
Glycogen synthase kinase-3 inhibition sensitizes pancreatic cancer cells to TRAIL-induced apoptosisIdentification of glycogen synthase kinase 3α as a therapeutic target in melanomaAberrant glycogen synthase kinase 3β is involved in pancreatic cancer cell invasion and resistance to therapy.Glycogen synthase kinase 3 protein kinase activity is frequently elevated in human non-small cell lung carcinoma and supports tumour cell proliferation.Resveratrol plays dual roles in pancreatic cancer cells.Glycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growthExploring protein kinase inhibitors: unveiling gemcitabine resistance in pancreatic cancer.GSK3β mediates the carcinogenic effect of HPV16 in cervical cancerAberrant glycogen synthase kinase 3β in the development of pancreatic cancer.Metabolic disorder, inflammation, and deregulated molecular pathways converging in pancreatic cancer development: implications for new therapeutic strategies.Glycogen synthase kinase 3β inhibition as a therapeutic approach in the treatment of endometrial cancer.Modulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells.Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-cateninTargeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo.Glycogen synthase kinase 3 beta: can it be a target for oral cancer.Challenges of drug resistance in the management of pancreatic cancer.Glycogen Synthase Kinase 3β in Pancreatic Cancer and its Implications in Chemotherapy and Radiation Therapy.GSK3β inactivation induces apoptosis of leukemia cells by repressing the function of c-Myb.Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells.CXCR4 promotes GSK3β expression in pancreatic cancer cells via the Akt pathway.Flavonoid apigenin modified gene expression associated with inflammation and cancer and induced apoptosis in human pancreatic cancer cells through inhibition of GSK-3β/NF-κB signaling cascade.PANC-1 cells proliferative response to ionizing radiation is related to GSK-3β phosphorylation.Molecular predictors of gemcitabine response in pancreatic cancer.Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer.Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine.
P2860
Q28729017-6D2B9539-8153-4CB8-85C5-BE926CA6E35EQ33569998-4B5E9434-EE0B-48C8-85EF-1DF82F284AADQ34585992-BC61A4F1-7261-4E5D-8F9E-0F1294C13D62Q34654039-57DCC07D-564C-48BF-8E88-DA6019D58B83Q35113534-70F20C7E-7F26-4D84-B5BC-D46E50EDE32BQ35281886-C5598D1F-A585-4058-A7E1-7D8CE5223FEEQ36033055-FAEBB6CE-2829-4FE4-910A-E9C77A76CF82Q36272771-B5653D6F-F7E0-4A1C-B8B5-FA4D1B86E545Q36450022-1A18F2C5-413B-4167-A192-72EF2C36659DQ37129787-3E74A357-10A6-44CF-BE5C-B96771DDBDE4Q37139199-5D50996C-C107-4543-90C3-1B32716AD270Q37687091-CCD73B4F-D821-454C-A13D-7EA61FF1F826Q37718335-5EED1A7E-9907-4531-BB25-68E264F4BB2DQ37718461-9A5197AD-9E20-41D7-83FE-F25F0BE39B28Q37764097-F7AF8D32-E714-4068-AD9B-E19567A50780Q37799830-CE50F34B-9B72-43FF-AEBA-14A85764F34EQ38221504-63474C16-EBF9-45F3-8C44-F1A941CBE07CQ38394964-31894062-6133-4FC2-A56A-1FC31C20CE0BQ38922877-B362ABDC-DB73-4967-887B-5A52D3AED695Q38964023-7E201100-8844-4E77-9E7E-8183643387CEQ39110471-AD9BD56D-AF9F-4C59-BE30-4803DFF046ACQ39235959-B63B6BD6-3C4E-4E7E-8617-F8A08CDC5279Q39250668-B90E7034-6B71-4229-8862-49C5DA72B03CQ39357705-4F30E4F4-0275-4416-9CF4-6359FB4774DFQ39450022-C2EDB8F3-896B-4E34-B809-C59CD66C3042
P2860
Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Glycogen synthase kinase-3 inh ...... ze to gemcitabine chemotherapy
@ast
Glycogen synthase kinase-3 inh ...... ze to gemcitabine chemotherapy
@en
type
label
Glycogen synthase kinase-3 inh ...... ze to gemcitabine chemotherapy
@ast
Glycogen synthase kinase-3 inh ...... ze to gemcitabine chemotherapy
@en
prefLabel
Glycogen synthase kinase-3 inh ...... ze to gemcitabine chemotherapy
@ast
Glycogen synthase kinase-3 inh ...... ze to gemcitabine chemotherapy
@en
P2860
P356
P1433
P1476
Glycogen synthase kinase-3 inh ...... ze to gemcitabine chemotherapy
@en
P2093
Satish Patel
Shadi Mamaghani
P2860
P2888
P356
10.1186/1471-2407-9-132
P407
P50
P577
2009-04-30T00:00:00Z
P5875
P6179
1038644817